Ambergen Inc.

WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board.
Cancer Weekly; 11/17/2009; 854 words; WaferGen Biosystems, Inc. (BULLETIN BOARD: WGBS) , a leading...currently the Chief Scientific Officer at Ambergen, responsible for overseeing the development...Therapy, Treatment, WaferGen Biosystems Inc. This article was prepared by Cancer...

Patent No. 7,563,598 Assigned to Ambergen for Detection of Truncation Mutations by Mass Spectrometry on July 21 (Massachusetts Inventors)
US Fed News Service, Including US State News; 7/24/2009; 381 words; ...mass spectrometry. The inventors were issued Patent No. 7,563,598 on July 21. The patent has been assigned to Ambergen Inc., Watertown, Mass. According to the abstract released by the U.S. Patent & Trademark Office: "This invention...

Studies from M. Lim et al in the area of proteomics described.
Blood Weekly; 1/1/2009; 847 words; ...103-115). For additional information, contact M. Lim, AmberGen, Watertown, MA 02472, USA. The publisher's contact information for the journal Analytical Biochemistry is: Academic Press Inc. Elsevier Science, 525 B St., Ste. 1900, San Diego, CA...

WIPO: Inventors in Massachusetts Develop Human Diseases Diagnosing Method
US Fed News Service, Including US State News; 10/31/2008; 486 words; ...invention carries International Patent Publication No. WO/2007/067719 on Sept. 18. The patent has been assigned to Ambergen Inc., Waltham, Mass. The original patent was filed in Massachusetts under application No. PCT/US2006/046796 on...

Massachusetts Inventors Develop Nascent Proteins Detection, Analysis Method
US Fed News Service, Including US State News; 1/1/2008; 459 words; ...dyes." The inventors were issued U.S. Patent No. 7,312,060 on Dec. 25. The patent has been assigned to Ambergen Inc., Watertown, Mass. The original application was filed on Jan. 10, 2003, and is available at: http://patft...